Tourmaline Bio, Inc.
TRML · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $31 | $141 | $8 | $19 |
| Short-Term Investments | $228 | $62 | $0 | $225 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $6 | $0 | $3 |
| Total Curr. Assets | $269 | $209 | $8 | $247 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $37 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $1 | $0 | $0 |
| Total NC Assets | $40 | $1 | $1 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $309 | $210 | $9 | $251 |
| Liabilities | – | – | – | – |
| Payables | $4 | $1 | $0 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $4 | $1 | $5 |
| Total Curr. Liab. | $9 | $5 | $1 | $8 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $27 | $1 |
| Total NC Liab. | $0 | $0 | $27 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $0 |
| Total Liabilities | $9 | $5 | $29 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$135 | -$62 | -$20 | -$91 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $435 | $267 | $0 | $334 |
| Total Equity | $300 | $205 | -$20 | $243 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $309 | $210 | $9 | $251 |
| Net Debt | -$30 | -$140 | -$8 | -$19 |